Leishmaniasis
Leishmaniasis(利什曼病)
Leishmaniasis 相关产品(21)
- GC43773Glyburide (potassium salt)CAS: 52169-36-5纯度: >98.00%
A sulfonylurea inhibitor of SUR1/K ir 6.2
- GC43825Histone H1-derived Peptide (trifluoroacetate salt)纯度: >95.00%
A peptide substrate for CRK3/CYC6
- GC45580Tizoxanide-d4CAS: 1246817-56-0纯度: >99.00%
An internal standard for the quantification of tizoxanide
- GC463861,3,6,8-Pyrenetetrasulfonic Acid (sodium salt hydrate)CAS: 1771776-02-3纯度: >95.00%
A synthetic intermediate
- GC464911-Palmitoyl-d9-2-hydroxy-sn-glycero-3-PECAS: 2747981-09-3纯度: >99.00%
A neuropeptide with diverse biological activities
- GC48659UmbellipreninCAS: 532-16-1; 23838-17-7纯度: >98.00%
A prenylated coumarin with diverse biological activities
- GC52434Marbofloxacin-d8 (hydrochloride)纯度: >99.00%
An internal standard for the quantification of marbofloxacin
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC18651 | 1-Palmitoyl-2-hydroxy-sn-glycero-3-PE | 53862-35-4 | >98.00% | |
A lysophospholipid | ||||
| GC41007 | 2,3-Dehydro-3,4-dihydro Ivermectin | 1135339-49-9 | >95.00% | |
An anthelmintic | ||||
| GC41281 | 2'-C-Methyladenosine | 15397-12-3 | >98.00% | |
An adenosine analog | ||||
| GC43773 | Glyburide (potassium salt) | 52169-36-5 | >98.00% | |
A sulfonylurea inhibitor of SUR1/K ir 6.2 | ||||
| GC43825 | Histone H1-derived Peptide (trifluoroacetate salt) | - | >95.00% | |
A peptide substrate for CRK3/CYC6 | ||||
| GC45580 | Tizoxanide-d4 | 1246817-56-0 | >99.00% | |
An internal standard for the quantification of tizoxanide | ||||
| GC46106 | Butyrolactone V | 1151509-01-1 | >95.00% | |
A fungal metabolite | ||||
| GC46386 | 1,3,6,8-Pyrenetetrasulfonic Acid (sodium salt hydrate) | 1771776-02-3 | >95.00% | |
A synthetic intermediate | ||||
| GC46491 | 1-Palmitoyl-d9-2-hydroxy-sn-glycero-3-PE | 2747981-09-3 | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC46544 | 2-Fluoro-4-iodo benzonitrile | 137553-42-5 | >98.00% | |
A building block | ||||
| GC46577 | 3,5-Dihydroxybenzaldehyde | 26153-38-8 | >98.00% | |
A building block | ||||
| GC46705 | 5-Methoxycanthinone | 15071-56-4 | >95.00% | |
An alkaloid with anticancer properties | ||||
| GC47723 | N,N-dimethyl Sphinganine (d18:0) | 17267-46-8 | >95.00% | |
A sphingolipid | ||||
| GC48461 | rac-trans-4-hydroxy Glyburide | 23155-00-2 | >98.00% | |
An active metabolite of glyburide | ||||
| GC48488 | 3-Oxobetulin Acetate | 136587-07-0 | >95.00% | |
A derivative of betulin | ||||
| GC48504 | Betulinic Aldehyde oxime | 25613-12-1 | >95.00% | |
A derivative of betulin | ||||
| GC48659 | Umbelliprenin | 532-16-1; 23838-17-7 | >98.00% | |
A prenylated coumarin with diverse biological activities | ||||
| GC48919 | Piliformic Acid | 98985-76-3 | >95.00% | |
A fungal metabolite | ||||
| GC49661 | Miltefosine-d4 | - | >99.00% | |
An internal standard for the quantification of miltefosine | ||||
| GC49786 | 2-NP-AOZ | 19687-73-1 | >95.00% | |
A derivatized metabolite of furazolidone | ||||
| GC52434 | Marbofloxacin-d8 (hydrochloride) | - | >99.00% | |
An internal standard for the quantification of marbofloxacin | ||||